[1]
J. C. Crema, “USE OF DAPAGLIFLOZIN (FORXIGA) IN THE TREATMENT OF HEART FAILURE: CURRENT EVIDENCE AND CLINICAL EFFICACY”, Editora, pp. 711–721, May 2026, doi: 10.56238/sevened2026.020-043.